China's Sinovac Biotech may not pursue COVID-19 vaccine trials in PH — DOST – Manila Bulletin

(Photo by Ali Vicoy / FILE PHOTO / MANILA BULLETIN)
DOST Secretary Fortunato “Boy” T. de la Peña said the Chinese vaccine developer has called off its plan to conduct its Phase 3 clinical trials in the Philippines after its SARS-CoV-2 vaccine Vero Cell Inactivated, or the CoronaVac was granted emergency use authorization (EUA) by the Food and Drug Administration (FDA).
“Yung Sinovac kasi nung naaprubahan ang EUA (emergency use authorization) nila, tinigil nila ang pagpursue ng clinical trials. Although nakikipag-usap pa rin sa possibility [of conducting the trials]…baka hindi na sila tumuloy kung kasama ng WHO (World Health Organization) ang Sinovac sa clinical trials, most likely hindi na sila magcli-clinical trials dito (When Sinovac got EUA for its vaccine, they stopped pursuing clinical trials. Although they were still talking to us about the possibility of conducting the trials…maybe they will not pursue if the WHO will include Sinovac in the clinical trials, most likely they will not conduct clinical trials here),” he said during the televised Laging Handa briefing.

Related Keywords

China ,Philippines ,United States ,De La Pe ,Philippines General ,Chinese ,American ,Eric Domingo ,Yung Sinovac ,Sinovac Biotech ,Clover Pharmaceuticals ,Department Of Science ,World Health Organization ,Janssen Pharmaceuticals ,Drug Administration ,Johnson ,Ali Vicoy ,Vero Cell Inactivated ,Laging Handa ,General Eric Domingo ,Belgium Based Janssen Pharmaceuticals ,Clover Biopharmaceutical ,சீனா ,பிலிப்பைன்ஸ் ,ஒன்றுபட்டது மாநிலங்களில் ,டி லா பே ,பிலிப்பைன்ஸ் ஜநரல் ,சீன ,அமெரிக்கன் ,எரிக் டொமிஂகொ ,க்ளோவர் மருந்துகள் ,துறை ஆஃப் அறிவியல் ,உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந் ,ஜான்சன் மருந்துகள் ,ஜான்சன் ,ஜநரல் எரிக் டொமிஂகொ ,பெல்ஜியம் அடிப்படையிலானது ஜான்சன் மருந்துகள் ,